Korea Union Pharmaceutical Acquires Convertible Bonds Worth 26.5 Billion KRW Before Maturity

Korea Union Pharmaceutical announced on the 4th that it will acquire the first series of anonymous, unsubordinated private convertible bonds with detachable warrants, worth approximately 26.5 billion KRW, before maturity. The conversion price per share is 11,124 KRW. The reason for the acquisition is the bondholders' exercise of the early redemption right (Put Option).